Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check6 days agoChange DetectedThe site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe footer now identifies the site as running revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history shows the site revision tag updated from v3.6.6 to v3.7.0, indicating a software release for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history and the previous v3.6.5 entry was removed, updating the historical record to reflect the latest published version.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, superseding the previous v3.6.4.SummaryDifference0.1%

- Check91 days agoChange DetectedRecord history includes a new revision entry v3.6.4, superseding v3.6.3. This reflects a minor metadata update to the page rather than changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.